RT Journal Article
SR Electronic
T1 1533 A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: efficacy and safety results from the open-label phase 2 SCOPE trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1756
OP A1756
DO 10.1136/jitc-2023-SITC2023.1533
VO 11
IS Suppl 2
A1 Shaw, Heather
A1 Patel, Poulam
A1 Payne, Miranda
A1 Kumar, Satish
A1 Danson, Sarah
A1 Highley, Martin
A1 Barlow, Clare
A1 Miller, Robert
A1 Master, Fayaz
A1 Durrant, Lindy
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1756.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.